ARCHIVES

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

Lasker Official Urges Congressional Support Of NCI Bypass Budget

April 20, 1990

Task Force Issues Guidless on LDCT Lung Screening

January 10, 2014

NCI Criticized For Delays In Development Of New Drugs

January 24, 1975

Also in this 8-page issue: Intel Chairman Andrew Grove slams NCI director and cancer program for “wishful dreams” and “chemo speeches,” recommends moratorium on funding for cancer research.

May 14, 2004

In Brief: Ortho Biotec gives $1 Million To Fund Fatigue Initiative; Lippman, Pike Honored

November 18, 1994

Retrovirus Vaccination Is Feasible, Workshop Participants Conclude

May 3, 1985